News | Radiation Oncology | May 18, 2021

Comprehensive approach to complex cases enables broad access to exceptional medical expertise from world-renowned specialists at Cleveland Clinic

The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis.

May 18, 2021 — The Clinic by Cleveland Clinic, a transformative joint venture between Cleveland Clinic and Amwell that aligns world-class clinical expertise with the power of innovative digital health technologies, announced that its virtual second opinion solution, available to health plans, employers and consumers, will now include multidisciplinary case analysis. The Clinic’s virtual second opinion offering provides patients, including those with complex medical conditions, the ability to obtain support from Cleveland Clinic’s world-renowned multidisciplinary panels, whose diversity of expertise ensures the most comprehensive and coordinated second opinion and treatment plan is offered.

“We chose to enter into the multi-disciplinary opinion space by offering services for brain tumor and prostate cancers because there are multiple treatment options for these patients,” said Peter Rasmussen, M.D., Chief Clinical Officer with The Clinic. “Given that these cancers can be treated with surgery, chemotherapeutics, and/or several different types of radiation, one physician isn't able to deliver a holistic opinion. Only multiple physicians from multiple specialties can provide the best recommendation to yield the highest quality of care and thereby the best value care. Our goal is to give patients access to Cleveland Clinic’s vast medical expertise from a variety of different perspectives for the best patient outcomes.”

According to a study published by the National Institutes of Health, more than 40% of cancer patients seeking a second opinion had a change in diagnosis as a result of multidisciplinary panel review, while 23% of patients were determined to present with additional, previously-undiagnosed cancers.

Added Frank McGillin, CEO of The Clinic, “Pairing patients who have complex medical conditions with coordinated support for multidisciplinary review reduces the risk of suboptimal treatment plans. It also protects them from higher-than-necessary healthcare expenses while providing peace of mind that they’re on the right path. For employers and health plans, the right diagnosis and treatment equates to better member outcomes and reduced costs of care.”

For more information: www.theclinic.io


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
Subscribe Now